Free Trial

Aptevo Therapeutics (APVO) Competitors

Aptevo Therapeutics logo
$3.03 +0.05 (+1.68%)
Closing price 04:00 PM Eastern
Extended Trading
$3.03 0.00 (0.00%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APVO vs. MBRX, LIXT, CHRO, XFOR, TRAW, EVOK, TSBX, BFRI, OBSV, and BMRA

Should you be buying Aptevo Therapeutics stock or one of its competitors? The main competitors of Aptevo Therapeutics include Moleculin Biotech (MBRX), Lixte Biotechnology (LIXT), Chromocell Therapeutics (CHRO), X4 Pharmaceuticals (XFOR), Traws Pharma (TRAW), Evoke Pharma (EVOK), Turnstone Biologics (TSBX), Biofrontera (BFRI), ObsEva (OBSV), and Biomerica (BMRA). These companies are all part of the "pharmaceutical products" industry.

Aptevo Therapeutics vs. Its Competitors

Moleculin Biotech (NASDAQ:MBRX) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

Moleculin Biotech has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Aptevo Therapeutics has a beta of 5.58, suggesting that its stock price is 458% more volatile than the S&P 500.

Moleculin Biotech has higher earnings, but lower revenue than Aptevo Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Moleculin BiotechN/AN/A-$21.76MN/AN/A
Aptevo Therapeutics$3.11M0.74-$24.13MN/AN/A

Moleculin Biotech's return on equity of -278.80% beat Aptevo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Moleculin BiotechN/A -278.80% -100.11%
Aptevo Therapeutics N/A -779.42%-175.59%

15.5% of Moleculin Biotech shares are held by institutional investors. Comparatively, 8.1% of Aptevo Therapeutics shares are held by institutional investors. 2.1% of Moleculin Biotech shares are held by company insiders. Comparatively, 0.0% of Aptevo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Moleculin Biotech presently has a consensus target price of $4.00, indicating a potential upside of 398.75%. Aptevo Therapeutics has a consensus target price of $219,040.00, indicating a potential upside of 7,228,942.90%. Given Aptevo Therapeutics' higher possible upside, analysts clearly believe Aptevo Therapeutics is more favorable than Moleculin Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Moleculin Biotech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aptevo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Moleculin Biotech had 1 more articles in the media than Aptevo Therapeutics. MarketBeat recorded 2 mentions for Moleculin Biotech and 1 mentions for Aptevo Therapeutics. Aptevo Therapeutics' average media sentiment score of 0.94 beat Moleculin Biotech's score of 0.64 indicating that Aptevo Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Moleculin Biotech
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aptevo Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Moleculin Biotech beats Aptevo Therapeutics on 7 of the 11 factors compared between the two stocks.

Get Aptevo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APVO vs. The Competition

MetricAptevo TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.25M$2.96B$5.54B$9.41B
Dividend YieldN/A2.46%3.75%4.03%
P/E RatioN/A8.2821.0120.09
Price / Sales0.74303.17433.8199.01
Price / CashN/A42.5936.1658.27
Price / Book0.057.678.125.65
Net Income-$24.13M-$55.28M$3.25B$257.91M
7 Day Performance1.00%2.50%0.97%2.09%
1 Month Performance-40.94%11.70%7.36%11.13%
1 Year Performance-99.98%4.89%31.31%18.40%

Aptevo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APVO
Aptevo Therapeutics
2.39 of 5 stars
$3.03
+1.7%
$219,040.00
+7,228,942.9%
-100.0%$2.25M$3.11M0.0050
MBRX
Moleculin Biotech
2.8568 of 5 stars
$0.63
+14.5%
$4.00
+534.8%
-81.2%$8.90MN/A0.0020High Trading Volume
LIXT
Lixte Biotechnology
0.2798 of 5 stars
$3.30
-16.9%
N/A+60.9%$8.84MN/A-2.284
CHRO
Chromocell Therapeutics
N/A$1.34
+6.3%
N/A-88.5%$8.69MN/A-1.084Gap Up
High Trading Volume
XFOR
X4 Pharmaceuticals
4.9282 of 5 stars
$1.48
+3.5%
$72.33
+4,787.4%
-93.3%$8.57M$2.56M0.6980Gap Up
High Trading Volume
TRAW
Traws Pharma
0.6817 of 5 stars
$1.54
+1.3%
N/AN/A$8.56M$230K-0.0517
EVOK
Evoke Pharma
1.2311 of 5 stars
$5.74
-4.5%
N/A-32.6%$8.55M$10.25M-2.004Gap Down
TSBX
Turnstone Biologics
2.4652 of 5 stars
$0.36
-2.0%
$0.45
+24.7%
-85.6%$8.35MN/A-0.1382Positive News
BFRI
Biofrontera
3.07 of 5 stars
$0.86
flat
$2.75
+219.8%
-26.0%$8.12M$38.00M-0.3870Positive News
Gap Up
OBSV
ObsEva
N/AN/AN/AN/A$7.94MN/A-0.1150
BMRA
Biomerica
1.3149 of 5 stars
$3.03
-3.8%
N/A+15.1%$7.73M$5.41M-1.3160Positive News

Related Companies and Tools


This page (NASDAQ:APVO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners